At its meeting on 18 July 2024, the Tariff Council reviewed the results of the analysis of the cost of guaranteed services covering musculoskeletal diseases in the area of spinal diseases. As a result of the discussion, the Council accepted the proposed direction of work and recommended further analysis and consultation with pediatric experts and also with representatives of Scientific Societies.
The Council reviewed the assumptions of the tariffing process for guaranteed benefits with a high degree of innovation, billed under product: 5.52.01.0001363 Billing with the consent of the payer.